<p>The anti-factor Xa assay is described in the experimental section. Data is presented as mean ± SD (n = 3).</p
This study was designed to evaluate anti-Xa activity hourly during the first 3 h after a single intr...
We describe a fully automated assay for determining effec-tive heparin activity in plasma, based on ...
This study was designed to evaluate anti-Xa activity hourly during the first 3 h after a single intr...
<p><b>(A)</b> PHA-induced release of cytokines (logarithmic scale) from PBMCs of healthy (n = 5) and...
A well-accepted test for monitoring anticoagulation by enoxaparin is not currently available. As ina...
Introduction: Co-administration of enoxaparin and a direct oral factor Xa inhibitor (xabans: apixaba...
Development, validation and application of in vitro (dosage forms) and in vivo (blood plasma) anti-X...
Background: Enoxaparin is one of the LMWH that has been used for long time in the treatment of acute...
<p>Ion-exchange chromatographic (IC) separation of enoxaparin. The separations were performed using ...
[No abstract available]6635861Lindahl, U., Hook, M., Backstrom, G., Stricture and biosynthesis of he...
unfractionated (UF) and low molecular weight (tMW) heparins have been measured in human plasma and w...
<p>Anti-FXa activity reflects the concentration of LMWH and the aPTT correlated well to this measure...
The quality and validity of laboratory results, especially for coagulation analyses, are influenced ...
Enoxaparin, a mixture of anticoagulant and non-anticoagulant fractions, is widely used as an anticoa...
The effect on haemostatic variables by dextran 70, enoxaparin and their combinations, given in doses...
This study was designed to evaluate anti-Xa activity hourly during the first 3 h after a single intr...
We describe a fully automated assay for determining effec-tive heparin activity in plasma, based on ...
This study was designed to evaluate anti-Xa activity hourly during the first 3 h after a single intr...
<p><b>(A)</b> PHA-induced release of cytokines (logarithmic scale) from PBMCs of healthy (n = 5) and...
A well-accepted test for monitoring anticoagulation by enoxaparin is not currently available. As ina...
Introduction: Co-administration of enoxaparin and a direct oral factor Xa inhibitor (xabans: apixaba...
Development, validation and application of in vitro (dosage forms) and in vivo (blood plasma) anti-X...
Background: Enoxaparin is one of the LMWH that has been used for long time in the treatment of acute...
<p>Ion-exchange chromatographic (IC) separation of enoxaparin. The separations were performed using ...
[No abstract available]6635861Lindahl, U., Hook, M., Backstrom, G., Stricture and biosynthesis of he...
unfractionated (UF) and low molecular weight (tMW) heparins have been measured in human plasma and w...
<p>Anti-FXa activity reflects the concentration of LMWH and the aPTT correlated well to this measure...
The quality and validity of laboratory results, especially for coagulation analyses, are influenced ...
Enoxaparin, a mixture of anticoagulant and non-anticoagulant fractions, is widely used as an anticoa...
The effect on haemostatic variables by dextran 70, enoxaparin and their combinations, given in doses...
This study was designed to evaluate anti-Xa activity hourly during the first 3 h after a single intr...
We describe a fully automated assay for determining effec-tive heparin activity in plasma, based on ...
This study was designed to evaluate anti-Xa activity hourly during the first 3 h after a single intr...
DOI
Add to ORKG